Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
05 June 2019 | Story Ruan Bruwer
Louzanne Coetzee
Athlete Louzanne Coetzee with the trophy of the Free State Sports Association for the Physically Disabled as Sports Star of the Year.

Although challenging, very exciting and a new journey, says Louzanne Coetzee about the athletics year for which she has been recognised.

The 26-year-old, who is doing her master’s in Social Cohesion and Reconciliation Studies at the University of the Free State, won the Free State Sports Association for the Physically Disabled (FSSAPD) Sports Star of the Year award for a fourth consecutive time. This was for the period June 2018 to April 2019.

In that time, she set a world record, an Africa record, and ran two marathons in which she came amazingly close to a second world record.

Only in her second marathon at the Berlin Marathon in September, the Paralympian fell 26 seconds short of the T11 (totally blind) world record time. She met the qualifying time for the 2020 Paralympic Games in Tokyo during the London Marathon in April.

“Marathons are definitely challenging and a new field for me, but I would say it has been a good 12 months. My aim is now set on next year’s Paralympic Games, where I would like to compete in the marathon and the 1 500 m.”

“I hope to run a good time in the 1 500 m at the World Para Athletics Championships in November.”

At the SASAPD National Championships for physically disabled and visually impaired athletes in April 2019, Coetzee won three gold medals and set a record in the 1 500 m. 

Others from the UFS also honoured

Coetzee has received several awards in her career, but says it is always special to be rewarded by her own federation (FSSAPD). 

Danie Breitenbach (T11) was also honoured as the Senior Male Sports Star. He bagged two gold medals and one silver and set a SA record in both the 800 m and 1 500 m at the nationals. Another Kovsie, Dineo Mokhosoa (F36 – coordination impairments), received a merit award for her gold medal in shot-put and silver in the discus at the national champs.

News Archive

UFS to monitor the use of ARV-drugs on pregnant women and children
2004-12-08

The University of the Free State (UFS) is to establish a Pharmacovigilance Centre that will monitor the effects of Anti-Retroviral (ARV) drugs on HIV positive pregnant women and children starting early in the new year.

The UFS is one of only two institutions chosen by the Minister of Health, Dr Manto Tshabalala-Msimang, to establish such an ARV monitoring centre.

The other centre will be based at Medical University of South Africa (MEDUNSA) and will concentrate mainly on monitoring the effects of the drugs on adults.

“The establishment of the UFS’s Pharmaconvigilance Centre forms part of government’s Comprehensive Plan on HIV and AIDS, often termed the roll-out plan for ARV drugs. The centre’s primary responsibility will be to specifically monitor the use of these drugs in pregnant women, and children under the age of 13,” said Prof Andrew Walubo of the UFS’s Department of Pharmacology.

“Although most of the side effects of ARV drugs have been identified in other countries, it has now become critical to identify the side effects amongst the South African population. This is important because many people will be exposed to the drugs within a short time. Our aim is so identify the most common side effects and make recommendations for the prevention thereof. The centre will help in detecting the risk of using anti-retroviral drugs in pregnancy and children, and prevention of adverse drug reactions,” said Prof Walubo.

According to Prof Walubo 12 drugs will be monitored – these drugs will be selected according to the patient’s profile.

The centre will comprise of two components: A pregnancy registry, which will focus on a new-born child up until two months and a pediatric registry, which will focus on children who are born of mothers who used ARV drugs and children using ARV drugs.

According to Prof Walubo, the Pharmaconvigilance Centre will also be responsible for offering relevant technical advice, training and selected research on ARV drugs in these patients.

The centre will be fully sponsored by the national Department of Health. It will be based in the UFS’s Faculty of Health Sciences, Department of Pharmacology, and will be run in collaboration with experts from different departments in the faculty.

Media release
Issued by: Lacea Loader
Media Representative
Tel: (051) 401-2584
Cell: 083 645 2454
E-mail: loaderl.stg@mail.uovs.ac.za
8 December 2004

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept